Source link : https://www.newshealth.biz/health-news/fda-adds-anaphylaxis-warning-to-ms-drug-glatiramer-acetate/
The US Food and Drug Administration (FDA) has added a boxed warning to the label of multiple sclerosis drug glatiramer acetate about the risk of anaphylaxis. From December 1996 through May 2024, 82 cases of anaphylaxis associated with glatiramer acetate were reported to the FDA Adverse Event Reporting System. Anaphylaxis associated with glatiramer acetate can occur […]
Author : News Health
Publish date : 2025-01-22 18:04:06
Copyright for syndicated content belongs to the linked Source.
inHealth